Michael Powell - Aug 9, 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/10/2021, 04:05 PM
Previous filing
Jun 17, 2021
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +30K $0.00 30K Aug 9, 2021 Common Stock 30K $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 9, 2021 with respect to 30,000 shares of the Issuer's common stock and shall vest in 12 equal monthly installments, subject to the Reporting Person's continuous service to the Issuer on each such date.